Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...

The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction.

Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million.

Private equity-backed US pharmaceutical giant Cosette has made a $672 million cash takeover bid for women’s health and dermatology group Mayne Pharmaceuticals. The company, which last week ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne ...